SE:SPAGONANOMEDICAL
Spago Nanomedical AB (publ)
- Stock
locale
Sweden
market
STOCKSindustry
Nanomedicinewebsite
spagonanomedical.selinkedin
spago-imaging-abfounding date
Jan 01, 2007ipo date
Jan 16, 2013
Spago Nanomedical AB (publ) develops nanomedicines for cancer diagnostics and treatment primarily in Sweden. It is involved in the development of SN132D, a gadolinium-free MRI contrast agent for the treatment of breast and pancreas cancer under the SpagoPix project; and SN201, a radionuclide therapy for treatment of advanced and metastatic cancer under the Tumorad project. The ...Show More